Description:

E5103 On-Study Form NCT00433511 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=22AFBF9F-D69B-53CC-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=22AFBF9F-D69B-53CC-E044-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 8/26/12
  2. 1/9/15
  3. 6/16/15
  4. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

E5103 On-Study Form NCT00433511

Instructions: Complete this form and submit original to the ECOG Coordinating Center within one week of registrations. Keep a copy for your files.

ECOG clinical trial administrative data
Reporting Period
Patient demographics
Performance status
ECOG Performance Status (Day 1 of this cycle)
Menopausal status (Definitions of Menopausal Status: Postmenopausal: Defined as at least one of the following: 1 age >55 with no spontaneous menses for at least 12 months; or 2 age </=55 with no spontaneous menses within the past 12 months e.g., spontaneously or...)
Pre-registration Evaluation
cm
Kg
Prior tamoxifen therapy
Prior raloxifene therapy? (for chemoprevention)
Pre-registration Scans/imaging
Method of Evaluation
Result
Disease Description
Tumor Laterality (NOTE: Submit copies of pathology reports for all diagnostic and therapeutic surgical procedures with E5103 Source Document Tracking Coversheet)
Breast: Surgical Procedures
Most Extensive Primary Surgery
Was sentinel node sampling performed
Was axillary dissection performed?
Breast: Disease Description
Histologic Grade (For breast cancer, a combined histologic grade is used according to SBR/Elston classification)
Nuclear Grade
Receptor Status, ER (as defined by local laboratory; borderline results should be reported as positive)
Receptor Status, PgR
Her2/neu expression status by immunohistochemistry (DAKO HercepTest)
Breast: Surgical Procedures
Breast: Disease Description
Footer Module

Similar models